Description of Organization and Business Operations (Details Narrative) - USD ($)										1 Months Ended	3 Months Ended	12 Months Ended
	Jul. 27, 2023	Jul. 07, 2023	May 30, 2023	May 30, 2023	May 18, 2023	Nov. 29, 2022	Jun. 17, 2021	Jun. 17, 2021	Jun. 02, 2021	Feb. 28, 2021	Mar. 31, 2024	Dec. 31, 2023	Jun. 30, 2024	Mar. 04, 2024	Jan. 30, 2024	Dec. 27, 2023	Nov. 27, 2023	Oct. 27, 2023	Sep. 27, 2023	Sep. 05, 2023	Aug. 31, 2023	Aug. 30, 2023	Aug. 28, 2023	Aug. 08, 2023	Jul. 28, 2023	Jun. 27, 2023	Jun. 01, 2023	Mar. 31, 2023	Mar. 13, 2023	Mar. 02, 2023	Feb. 02, 2023	Dec. 30, 2022	Dec. 01, 2022	Jun. 02, 2022	Jun. 18, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Condition for future business combination number of businesses minimum											1
Purchase price, per unit						$ 10.32
Transaction costs									$ 690,542
Underwriting discount									2,065,200
Deferred underwriting discount									3,614,100
Fair value of underwriter shares									1,033,633
Other offering costs									769,518
Transaction costs including accumulated deficit									$ 6,791,909
Share price						$ 0.067							$ 0.037	$ 0.037	$ 0.037	$ 0.037	$ 0.037	$ 0.037	$ 0.037		$ 0.037	$ 0.037			$ 0.037	$ 0.037	$ 0.037	$ 0.067		$ 0.067	$ 0.067	$ 0.067	$ 0.067
Amount trust account on each public shares						$ 125,000
Assets held in trust						$ 87,541,322							$ 30,000	$ 30,000	$ 30,000	$ 30,000	$ 30,000	$ 30,000	$ 30,000		$ 30,000	$ 30,000			$ 30,000	$ 30,000	$ 30,000	$ 125,000		$ 125,000	$ 125,000	$ 125,000	$ 125,000
Sponsor fees, description					he Company and Sponsor, announced that, the Company entered into an unsecured, interest-free promissory note in favor of the Sponsor, pursuant to which the Sponsor will loan the Company $30,000 per month for up to 12, 1-month extensions, up to an aggregate of $360,000. (See below regarding the current extensions exercised.)
Sponsor fees					$ 30,000
Aggregate value					$ 360,000
Business combination term			100
Common Stock, Voting Rights			the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at this special meeting, holders of 1,035,788 shares of Class A common stock (the “Redeeming Stockholder”) exercised the right to redeem such shares. On June 2, 2023, the Company made cash payments to the Redeeming Stockholders totalling $11,233,821, representing approximately $10.84 per share. Following such payments to the Redeeming Stockholders, the Trust Account had a balance of approximately $8,814,443. The Company’s remaining shares of Class A common stock outstanding were 812,715.
Other description	On July 27, 2023, the Company filed a Current Report on Form 8-K stating that the Company fully intends to appeal such determination by requesting a hearing to the Hearings Panel (the “Panel”), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series to stay the suspension of the Company’s securities and the filing of the Form 25-NSE pending the Panel’s decision, and on such date the Company requested the hearing, and wired the $20,000 fee to Nasdaq for the hearing, prior to 4:00 p.m. Eastern Time on August 1, 2023, as required in the Delisting Letter. The hearing with the Panel was then scheduled for September 21, 2023 (the “Hearing”).
Addition securities																				$ 28,706,280			$ 38,891,922
Marketable securities current																				$ 10,185,642			$ 35,000,000
Stock closing price, per share																				$ 11.12
Franchise and income tax withdrawals from trust account description											the Company withdrew $789,975 from the Trust Account to pay its liabilities related to the Delaware franchise taxes and income taxes. Through March 31, 2024, the Company remitted $521,931 to the respective tax authorities. Additionally, as of March 31, 2024, the Company had accrued but unpaid liability of $102,558 related to its income and Delaware franchise tax obligations. The difference between actual withdrawals and allowable withdrawals was recorded as a distribution to sponsor within the statement of changes in stockholders deficit in the amount of $107,827 for the year ended December 31, 2023 and $90,822 in the quarter ended March 31, 2024.
Cash											$ 17,183
Working capital deficit											6,083,979
Sales											25,000
Related parties investors											1,829,539	$ 1,729,539
Number of common shares elected to redeem				1,035,788
Liability on trust redemptions											$ 112,338
Maximum [Member] | Merger Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Merger consideration		$ 96,000,000
Minimum [Member] | Merger Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Merger consideration		$ 95,000,000
Trust Account [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Unsecured debt			$ 360,000	$ 360,000
Common Class B [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of private placement warrants (in shares)																													2,581,500
Convertible, per share																								$ 0.0001
Common Class A [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Convertible, per share																								$ 0.0001
Private Placement Warrants [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of private placement warrants (in shares)																													5,869,880					1,548,900
Exercise price of warrants																																		$ 1.00
Public Warrants [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Exercise price of warrants																																		$ 0.15
Public Warrants [Member] | Common Class A [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Exercise price of warrants											$ 11.50
Share price											$ 9.20
Common Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of private placement warrants (in shares)						8,477,497
IPO [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of units issued									10,000,000
Purchase price, per unit									$ 10.00
Proceeds from initial public offering, net of underwriting discount									$ 100,000,000
Transaction costs									$ 7,482,451
IPO [Member] | Maximum [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of units issued										11,500,000
Private Placement [Member] | Private Placement Warrants [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of private placement warrants (in shares)							97,800	97,800	4,571,000
Warrants price (in dollars per share)									$ 1.00
Proceeds from sale of Private Placement Warrants								$ 97,800	$ 4,571,000
Exercise price of warrants							$ 1.00	$ 1.00	$ 1.00
Private Placement [Member] | Private Placement Warrants [Member] | Sponsor [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of private placement warrants (in shares)									3,871,000																										74,980
Private Placement [Member] | Private Placement Warrants [Member] | Maxim Groups Llc [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of private placement warrants (in shares)									700,000
Over-Allotment Option [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of units issued							326,000	326,000	1,500,000		1,500,000
Purchase price, per unit							$ 10.00	$ 10.00	$ 10.00
Proceeds from initial public offering, net of underwriting discount								$ 3,260,000
Proceeds from issuance of units							$ 3,260,000
Underwriting fees							$ 65,200	$ 65,200